Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Sunho Biologics,Inc. ( (HK:2898) ) just unveiled an announcement.
Sunho Biologics, Inc. has announced a board meeting scheduled for March 31, 2025, to review and approve the company’s annual results for the year ending December 31, 2024. This meeting is significant as it will address the company’s financial performance and other business matters, potentially impacting its market positioning and stakeholder interests.
More about Sunho Biologics,Inc.
Sunho Biologics, Inc. is a company incorporated in the Cayman Islands, operating in the biotechnology industry. It focuses on developing and providing biological products and services, with a market presence reflected in its listing on the Hong Kong Stock Exchange.
YTD Price Performance: 13.03%
Average Trading Volume: 5,215
Technical Sentiment Consensus Rating: Strong Buy
See more insights into 2898 stock on TipRanks’ Stock Analysis page.